BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22666325)

  • 1. Rituximab for children with immune thrombocytopenia: a systematic review.
    Liang Y; Zhang L; Gao J; Hu D; Ai Y
    PLoS One; 2012; 7(5):e36698. PubMed ID: 22666325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excellent response to treatment with hydroxychloroquine in pediatric patients with SLE-related immune thrombocytopenia.
    Brik-Simon D; Efros O; Levinsky Y; Amarilyo G; Tirosh I; Levy-Mendelovich S; Steinberg-Shemer O; Izraeli S; Yacobovich J; Gilad O
    Pediatr Blood Cancer; 2024 May; 71(5):e30911. PubMed ID: 38348516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to rituximab in children and adults with immune thrombocytopenia (ITP).
    Harris EM; Hillier K; Al-Samkari H; Berbert L; Grace RF
    Res Pract Thromb Haemost; 2021 Aug; 5(6):e12587. PubMed ID: 34466770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term fostamatinib treatment of adults with immune thrombocytopenia during the phase 3 clinical trial program.
    Bussel JB; Arnold DM; Boxer MA; Cooper N; Mayer J; Zayed H; Tong S; Duliege AM
    Am J Hematol; 2019 May; 94(5):546-553. PubMed ID: 30784097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of splenic embolization in immune thrombocytopenia: A systematic review and meta-analysis.
    Egbaria A; Touma E; Cohen-Abadi M; Bisharat N
    Br J Haematol; 2024 May; 204(5):1966-1976. PubMed ID: 38544461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune thrombocytopenic purpura after influenza vaccine administration; a systematic review and meta-analysis.
    Elsaid M; Nune A; Brakat AM; Anand A; Alashwah M; Maher A; Lama N; Peñamante CAC
    Trop Dis Travel Med Vaccines; 2023 Nov; 9(1):22. PubMed ID: 38001495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dapsone for paediatric chronic immune thrombocytopenia: Short report from a tertiary centre in South India.
    Bharadwaj N; Munireddy J; Selvam S; Bharadwaj V; Prakash A
    Br J Haematol; 2024 Mar; 204(3):1024-1028. PubMed ID: 38220217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of critical bleeding events in patients with immune thrombocytopenia: a protocol for a systematic review and meta-analysis.
    Sirotich E; Nazaryan H; Chowdhury SR; Guyatt G; Agarwal A; Leong R; Wen A; Xu E; Liu B; Pallapothu S; Rathod P; Kwon HY; Dookie J; Shafiee A; Charness J; DiRaimo J; Paynter D; Pruitt B; Strachan G; Couban R; Ye Z; Arnold DM
    Syst Rev; 2024 Jan; 13(1):21. PubMed ID: 38184622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric refractory immune thrombocytopenia: A systematic review.
    Ibrahim L; Dong SX; O'Hearn K; Grimes AB; Kaicker S; FritchLilla S; Breakey VR; Grace RF; Lebensburger JD; Klaassen RJ; Lambert M
    Pediatr Blood Cancer; 2023 Mar; 70(3):e30173. PubMed ID: 36579787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab versus Splenectomy in Chronic Primary ITP: Experience of a Single Hematology Clinic.
    Shamoon RP; Yassin AK; Alnuaimy SL
    Mediterr J Hematol Infect Dis; 2024; 16(1):e2024019. PubMed ID: 38468837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab alleviates pediatric systemic lupus erythematosus associated refractory immune thrombocytopenia: a case-based review.
    Mu F; Bai X; Lou Y; Luo P; Guo Q
    Immunol Res; 2024 Jan; ():. PubMed ID: 38279058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical study reveals the efficacy of sirolimus in treating primary immune thrombocytopenia: findings from a single-center study.
    Feng Y; Meng H; Mu C; Zhang Y; Liu X; Shi Y; Wang H
    Blood Coagul Fibrinolysis; 2024 Jun; 35(4):155-160. PubMed ID: 38625834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of mycophenolate mofetil in patients with immune thrombocytopenic purpura: a systematic review and meta-analysis.
    Abdelwahab OA; Mechi A; Gahlan S; Hamadein FE; Kadhim H; Ismail D; Soliman Y; El-Samahy M
    Clin Rheumatol; 2024 Feb; 43(2):621-632. PubMed ID: 37981614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of azathioprine in immune thrombocytopenia.
    Mishra K; Pramanik S; Sandal R; Jandial A; Sahu KK; Singh K; Khera S; Meshram A; Khurana H; Somasundaram V; Kumar R; Kapoor R; Verma T; Sharma S; Singh J; Das S; Chaterjee T; Sharma A; Nair V
    Am J Blood Res; 2021; 11(3):217-226. PubMed ID: 34322284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of secondary immune thrombocytopenia following alemtuzumab treatment for multiple sclerosis: a systematic review and meta-analysis.
    Sun Y; Liu Z; Yang J; Jia Q; Sun J; Wang L; Liang F; Song S; Wang K; Zhou X
    Front Neurol; 2024; 15():1375615. PubMed ID: 38660089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Efficacy of High-Dose Dexamethasone vs. Other Treatments for Newly Diagnosed Immune Thrombocytopenia: A Meta-Analysis.
    Xiao Q; Lin B; Wang H; Zhan W; Chen P
    Front Med (Lausanne); 2021; 8():656792. PubMed ID: 34113634
    [No Abstract]   [Full Text] [Related]  

  • 17. 2022 Review of the 2019 American Society of Hematology Guidelines on Immune Thrombocytopenia.
    Neunert CE; Arnold DM; Grace RF; Kühne T; McCrae KR; Terrell DR
    Blood Adv; 2024 Apr; ():. PubMed ID: 38608258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations for the Clinical Approach to Immune Thrombocytopenia: Spanish ITP Working Group (GEPTI).
    Mingot-Castellano ME; Canaro Hirnyk M; Sánchez-González B; Álvarez-Román MT; Bárez-García A; Bernardo-Gutiérrez Á; Bernat-Pablo S; Bolaños-Calderón E; Butta-Coll N; Caballero-Navarro G; Caparrós-Miranda IS; Entrena-Ureña L; Fernández-Fuertes LF; García-Frade LJ; Gómez Del Castillo MDC; González-López TJ; Grande-García C; Guinea de Castro JM; Jarque-Ramos I; Jiménez-Bárcenas R; López-Ansoar E; Martínez-Carballeira D; Martínez-Robles V; Monteagudo-Montesinos E; Páramo-Fernández JA; Perera-Álvarez MDM; Soto-Ortega I; Valcárcel-Ferreiras D; Pascual-Izquierdo C;
    J Clin Med; 2023 Oct; 12(20):. PubMed ID: 37892566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced immune-mediated thrombocytopenia secondary to durvalumab use.
    Dougherty SC; Lynch AC; Hall RD
    Clin Case Rep; 2021 Jun; 9(6):e04227. PubMed ID: 34188921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which pediatric ITP patients will go on to lupus?
    Neufeld EJ
    Blood; 2024 Apr; 143(16):1553-1554. PubMed ID: 38635255
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.